Literature DB >> 21193464

Increasing the proportion of autologous arteriovenous fistulas does not diminish fistula patency.

Jean Marie Ruddy1, Thomas E Brothers, Jacob G Robison, Bruce M Elliott.   

Abstract

OBJECTIVE: Arteriovenous fistulas (AVF) constructed before and after initiating the kidney disease outcomes and quality initiative (KDOQI) guidelines were reviewed at a single academic center to identify decreased patency with use of potentially inferior vein conduits.
METHODS: Primary access procedures performed pre- and post-adoption of KDOQI guidelines were compared for the primary outcomes of maturation rate and primary patency and the secondary outcome of access utilization.
RESULTS: The proportion of autologous AVFs created was higher post-KDOQI (73% vs 35%, P < .001), and an increased use of the basilic vein was observed (20% vs 2%, P < .05). The failure rate of fistula maturation was reduced post-KDOQI (24% vs 38%, P < .05); however, access utilization was also decreased (59% vs 75%, P < .001).
CONCLUSIONS: Adherence to KDOQI guidelines for AVFs does not compromise fistula patency and increased use of the basilic vein may lead to superior fistula maturation rates. Early referral may result in lower fistula utilization rates, however.

Entities:  

Mesh:

Year:  2011        PMID: 21193464     DOI: 10.1177/1538574410388310

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  A Prospective, Randomized Trial of Routine Duplex Ultrasound Surveillance on Arteriovenous Fistula Maturation.

Authors:  Ahram Han; Seung-Kee Min; Mi-Sook Kim; Kwon Wook Joo; Jungsun Kim; Jongwon Ha; Joongyub Lee; Sang-Il Min
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-24       Impact factor: 8.237

2.  A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation.

Authors:  Eric K Peden; David B Leeser; Bradley S Dixon; Mahmoud T El-Khatib; Prabir Roy-Chaudhury; Jeffrey H Lawson; Matthew T Menard; Laura M Dember; Marc H Glickman; Pamela N Gustafson; Andrew T Blair; Marianne Magill; F Nicholas Franano; Steven K Burke
Journal:  J Vasc Access       Date:  2012-11-20       Impact factor: 2.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.